急性冠状动脉综合征的炎症机制:从病理生理学到治疗点
Daniel Miron Brie1,2, Cristian Mornoș1,2,3, Ovidiu Adam4
1Cardiovascular Disease Institute Timisoara, Gheorghe Adam Street, No. 13A, 300310 Timisoara, Romania.
Cells
|January 9, 2026
概括
炎症导致急性冠状动脉综合征 (ACS). 向炎症通路的治疗方法,如胆固醇和IL-1β抑制,显示出改善传统风险因素之外的心血管结果的希望.
科学领域:
- 心血管医学 心血管医学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 炎症是急性冠状动脉综合征 (ACS) 发病的核心原因,导致斑块不稳定,血栓形成和心脏损伤.
- 了解复杂的炎症途径对于开发有效治疗方法至关重要.
研究的目的:
- 审查ACS中的炎症机制.
- 评估当前和新兴的抗炎疗法用于ACS管理.
主要方法:
- 在ACS.中炎症途径的综合文献综述.
- 对ACS中抗炎疗法的临床试验数据的分析.
主要成果:
- ACS涉及先天性和适应性免疫细胞之间的复杂相互作用,包括中性粒细胞,巨细胞和T淋巴细胞.
- 关键的机制包括中性粒细胞外细胞陷 (NET) 形成,巨细胞极化和T细胞失衡.
- 像C-反应蛋白和IL-6这样的生物标志物表明预后,而像胆固醇和卡纳基努马布 (IL-1β抑制) 这样的疗法证明了心血管方面的益处.
结论:
- 炎症是ACS的关键治疗点,提供了超越传统风险因素管理的好处.
- 针对特定炎症途径的精准医学方法对未来充满希望.
- 将抗炎症策略与脂质管理和抗血栓治疗相结合,可以提高ACS的结果.
相关概念视频
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
347
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
347
Acute Coronary Syndrome IV: Interprofessional Care
214
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
214
Acute Coronary Syndrome I: Introduction
785
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
785
Coronary Artery Disease II: Pathophysiology
360
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
360
Acute Coronary Syndrome III: Diagnostic Studies
207
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
207
Coronary Artery Disease V: Interprofessional Care
210
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
210


